| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methoxy-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_001145210.3 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 441869 |
| UniProt ID | E5RJM6 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methoxy-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_001145210.3 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 441869 |
| UniProt ID | E5RJM6 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD65, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) (GTTS-WK18834MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK5421MR | IVTScrip™ mRNA-Human Go-alpha, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) | mRNA | Go-alpha |
| GTTS-WK14609MR | IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) | mRNA | ANKRD20A8P |
| GTTS-WK18817MR | IVTScrip™ mRNA-Human ANKRD31, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) | mRNA | ANKRD31 |
| GTTS-WK28341MR | IVTScrip™ mRNA-Human ARL4A, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) | mRNA | ARL4A |
| GTTS-WK17623MR | IVTScrip™ mRNA-Human ANKRD37, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) | mRNA | ANKRD37 |
| GTTS-WK19336MR | IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | alpha-Sarcoglycan |
| GTTS-WK3735MR | IVTScrip™ mRNA-Human CD9, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) | mRNA | CD9 |
| GTTS-WK26768MR | IVTScrip™ mRNA-Human ARF6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) | mRNA | ARF6 |